Abstract WP398: Timing of Starting Doacs and Short- and Long-Term Clinical Outcomes for Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation: The Samurai-nvaf Study

Tadataka Mizoguchi(National Cerebral and Cardiovascular Center), Ḱazunori Toyoda(National Cerebral and Cardiovascular Center), Tadashi Terasaki(Japanese Red Cross Kumamoto Hospital), Yoshiki Yagita(Kawasaki Medical School), Kenichi Todo(Osaka City University), Masatoshi Koga(National Cerebral and Cardiovascular Center), Ryo Itabashi(Iwate Medical University), Toshihiro Ide(Saga University), Takeshi Yoshimoto(University Hospital of Basel), Hiroshi Yamagami(Osaka City University), Shoichiro Sato(National Cerebral and Cardiovascular Center), Masahito Takagi(National Cerebral and Cardiovascular Center), Masayuki Shiozawa(National Cerebral and Cardiovascular Center)
Stroke
January 22, 2018
10.1161/str.49.suppl_1.wp398
Cited by 0

Related Papers

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
|The Lancet|2019|271
High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)
|Circulation|2018|245
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation
|New England Journal of Medicine|2023|217